Advanced Cancers: Testing IPH4502

We are investigating the safety and effects of a new drug, IPH4502, in people with advanced cancers. This study aims to understand how the drug works in humans for the first time.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Leon Berard
Medical Oncology
Meyzieu, France
Institut Gustave Roussy
Early Drug Development and Genitourinary Oncology Group
Villejuif, France
Sponsor: Innate Pharma
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.